ESGO-ENYGO-ESO Masterclass in Gynaecological Oncology
Not eligible for ESCO credits
14.06.2018 - 16.06.2018
Warsaw, Poland
MASTERCLASS
Description
Scientific and Organising Committe: D. Querleu, FR - K. Zalewski, PL - F. Peccatori, IT
After two successful previous editions [Madrid (2014), Lund (2016)], the ESGO-ENYGO-ESO Masterclass 2018 will present up-to-date, standardised knowledge of the multidisciplinary management of gynaecological cancers to future gynaecological oncologists. The course furthers the organisations’ key goal of harmonising gynaecological oncology training and education throughout Europe.
COURSE HIGHLIGHTS
• Entire curriculum focused on gynae-oncological subspecialty theory
• State of the art lectures, video sessions, and interactive tumour boards
• Tracks on pelvic anatomy, diagnosis and treatment of cervical, vulvar, endometrial, and ovarian cancers
• Miscellaneous topics : perioperative and supportive care, fertility preservation, management of treatment complications, and palliative care
• Case reports presented by participants and interactively discussed at each track
• International faculty
TEACHING FORMAT AND LEARNING OBJECTIVES
This full-immersion, clinically oriented, multidisciplinary event offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines. State-of-the-art lectures will be combined with practical video presentations of surgical approaches and tumour boards. This year, following previous participants’ feedback, discussion and tumour board time will be extended. In addition, to make the event even more interactive, we invite attendees to send us their own clinical cases (3-5 slides) prior to the course. Selected participants will have a unique opportunity to present and discuss their case study.
After the Masterclass, participants will have a full picture of the basics of different gynaecological cancers, their treatment, and care in compliance with the ESGO-defi ned standards of training in gynaecological oncology.
Held in cooperation with |
|||||||
![]() |
![]() |
Faculty
SCIENTIFIC AND ORGANIZING COMMITTEE
Denis Querleu, ESGO President Elect, Bordeaux, France
Kamil Zalewski, Local Chair, ENYGO Executive Group member, Kielce, Poland
Fedro Peccatori, ESO Scientific Director, Milan, Italy
FACULTY
D. Querleu, ESGO President, Institut Bergonié Cancer Center, Bordeaux, FR
F. Peccatori, ESO Scientific Director, Department of Gynaecologic Oncology of the European Institute of Oncology, Milan, IT
K. Zalewski, ENYGO President, Department of Gynecologic Oncology, Holycross Cancer Center, Kielce, Poland, Warsaw Medical University, PL
D. Cibula, ESGO Past President, Gynaecology Oncology Center, Department of Obstetrics and Gynaecology, Charles University Prague, CZ
A. Fagotti, Member of ESGO Council, Fondazione Policlinico A. Gemelli/Catholic University of the Sacred Heart, Rome, IT
C. Fotoloulou, Member of ESGO Council, Department Of Gynecology, Imperial College London, NHS Trust, UK
M. J. Halaska, Dept. of Obstetrics and Gynaecology, 3rd Medical Faculty, Charles University in Prague and Faculty Hospital Kralovske Vinohrady, CZ
D. Lindquist, ENYGO Vice-President, SE
R. Jach, Chair, Gynecology and Endocrinology, Department of Obstetrics and Gynecology, University Hospital in Krakow, Poland, Jagiellonian University, PL
P. Knapp, Member of ESGO Council, Department of Gynaecology and Gynaecologic Oncology, Medical University of Bialystok, PL
R. Madry, Poznan University Of Medical Sciences, PL
M. Mirza, Member of ESGO Council, Core Faculty, European School of Oncology, Department of Oncology, Rigshospitalet, Copenhagen, DK
General information
ORGANISING SECRETARIAT
ESGO Office
Palace YMCA, Na Porici 12/1041
110 00 Prague 1
Czech Republic
Email: masterclass2018@esgomail.org
Event website: www.esgo.org/masterclass-2018
GENERAL INFORMATION
The ideal Masterclass candidate is a trainee or fellow in gynaecological oncology who holds ENYGO membership and speaks fluent English.
The Masterclass will be held at the auditorium of the Medical University of Warsaw, Poland.
Course attendance is limited to 80 participants; registrations will be treated on a first-come-first-served basis. Priority will be given to people who have not yet participated in a Masterclass. The official course language is English.
Accommodation
TRAVEL
Attendees are responsible for their own travel arrangements.
ACCOMMODATION
Hotel:
Airport Hotel Okecie, ul. 17 Stycznia 24, 02-146 Warszawa, Poland
https://airporthotel.pl
Accommodation for 2 nights in a double room, in a standard hotel in the vicinity of the course venue will be arranged and covered by ESGO from Thursday, June 14 (check in) until Saturday, June 16, 2016 (check out).
In case that you need an extra night (paid directly by yourself) on the day before/after the workshop, we can arrange that directly with the hotel. In such a case be so kind and inform us in due time.
Programme
14 June
12:00 | Registration |
|
13:00 | Welcome ESGO/ENYGO/ESO D. Querleu, FR - F. Peccatori, IT - K.Zalewski, PL |
|
PELVIC ANATOMY applied to gynaecological cancer surgery Chair: A. Fagotti, IT |
||
13:15 | Surgical spaces, lymphatic drainage, nerves, topography D. Querleu, FR |
|
CERVICAL CANCER I Chairs: A. Fagotti, IT - D. Querleu, FR |
||
13:35 | Epidemiology and histopathology of cervical cancer R. Jach, PL |
|
13:55 | Ultrasound, MRI, staging in cervical cancer M. Halaska, CZ |
|
14:20 | Management of early invasive carcinoma (Stage IA1, IA2, IB1, IIA1) D. Cibula, CZ |
|
14:40 | Management of locally advanced cervical carcinoma (IB2, >IIA2) R. Jach, PL |
|
15:00 | Management of primary metastatic, persistent and recurrent cervical cancer R. Madry, PL |
|
15:30 | Lunch |
|
CERVICAL CANCER II Chairs: M. Halaska, CZ - R. Jach, PL |
||
16:30 | Video of laparoscopic pelvic lymphadenectomy A. Fagotti, IT |
|
16:40 | Video of radical hysterectomy (including nerve sparing) D. Cibula, CZ |
|
16:50 | Fertility sparing procedures in cervical carcinoma (trachelectomy, NAC) M. Halaska, CZ |
|
17:10 | Workshop 1: Presentation of selected clinical cases by participants with discussion Chairs: D. Lindquist, SE - D. Cibula, CZ |
|
17:30 | Tumor board: Cervical cancer (IB2, IIIB, recurrence) Discutants: D. Lindquist, SE - D. Cibula, CZ - D. Querleu, FR - R. Jach, PL - D. Cibula, CZ - R. Madry, PL - F. Peccatori, IT - A. Fagotti, IT - M. Halaska, CZ |
|
18:10 | Discussion |
|
18:30 | End of the day |
15 June
VULVAR CANCER Chairs: P. Knapp, PL - A. Fagotti, IT |
||
9:00 | Epidemiology and histopathology of vulvar cancer Local pathologist |
|
9:15 | Primary treatment of early stage vulvar cancer K. Zalewski, PL |
|
9:35 | Management of advanced stage and recurrent vulvar cancer M. Mirza, DK |
|
10:00 | Video: Radical vulvectomy and groin node dissection, SLNM M. Halaska, CZ |
|
10:10 | Workshop 2: Presentation of selected clinical cases by participants with discussion Chairs: M.Mirza, DK - K. Zalewski, PL |
|
10:30 | Tumor board: Vulvar cancer (IB, IIIA, recurrence) Discutants: A. Fagotti, IT - P. Knapp, PL - D. Cibula, CZ - M. Halaska, CZ - K. Zalewski, PL - M.Mirza, DK |
|
11:00 | Coffee break |
|
MALIGNANT TUMOURS OF THE UTERUS I Chairs: F. Peccatori, IT - Ch. Fotopoulou, UK |
||
11:30 | Epidemiology and histopathology of hyperplasia and endometrial cancer Local pathologist |
|
11:50 | Diagnosis and staging of endometrial cancer P. Knapp, PL |
|
12:10 | Surgical management of endometrial cancer D. Querleu, FR |
|
12:30 | Adjuvant treatment of endometrial cancer M. Mirza, DK |
|
13:00 | Overview of treatment of advanced, recurrent or metastatic endometrial cancer R. Madry, PL |
|
13:30 | Lunch |
|
MALIGNANT TUMOURS OF THE UTERUS I Chairs: F. Peccatori, IT - Ch.Fotopoulou, UK |
||
14:00 | Video: Open paraaortic lymphadenectomy Ch. Fotopoulou, UK |
|
14:15 | Video: Laparoscopic paraaortic lymphadenectomy D. Querleu, FR |
|
14:30 | Fertility preserving options in endometrial cancer P. Knapp, PL |
|
14:50 | Diagnosis and management of uterine sarcoma M. Halaska, CZ |
|
15:10 | Coffee break |
|
16:00 | Workshop 3: Presentation of selected clinical cases by participants with discussion Chairs: D. Cibula, CZ - D. Lindquist, SE |
|
16:20 | Tumor board: endometrial cancer (IBG2, IIIA, recurrence) Discutants: D. Cibula, CZ - D. Lindquist, SE - D. Querleu, FR - M. Mirza, DK - Ch. Fotopoulou, UK - R. Madry, PL - M. Halaska, CZ - P. Knapp, PL - F. Peccatori, IT - A. Fagotti, IT |
|
17:00 | Discussion |
|
17:20 | Familial Gynaecological Cancer - risk assessment and management F. Peccatori, IT |
|
17:50 | Perioperative care Ch. Fotopoulou, UK |
|
18:10 | End of the day |
16 June
MISCELLANEOUS 2 Chairs: D. Lindquist, SE - F. Peccatori, IT |
||
9:00 | Symptom control and pain management (palliative care) A. Fagotti, IT |
|
9:30 | Management of surgical complications D. Cibula, CZ |
|
9:50 | Supportive care and management of side effects of chemotherapy (incl. targeted therapy) R. Madry, PL |
|
MALIGNANT TUMOURS OF THE OVARIES Chairs: Ch. Fotopoulou, UK - R. Madry, PL |
||
10:10 | Epidemiology and histopathology of ovarian cancer Local pathologist |
|
10:30 | Diagnosis and staging of ovarian cancer A. Fagotti, IT |
|
10:50 | Surgical management of primary and recurrent ovarian cancer D.Querleu, FR |
|
12:30 | Coffee break |
|
13:00 | Video: surgical procedures in advanced ovarian cancer Ch. Fotopoulou, UK |
|
13:20 | Adjuvant treatment in early, advanced and recurrent ovarian cancer M. Mirza, DK |
|
14:00 | Management of non-epithelial ovarian malignancies F. Peccatori, IT |
|
14:20 | Workshop 4: Presentation of selected clinical cases by participants with discussion Ch. Fotopoulou, UK - M. Mirza, DK |
|
14:40 | Tumor board: ovarian cancer Discutants: D. Querleu, FR - Ch. Fotopoulou, UK - D. Cibula, CZ - F. Peccatori, IT - R. Madry, PL - M. Mirza, DK |
|
15:10 | Discussion |
|
15:30 | Closing remarks D. Querleu, FR - F. Peccatori, IT - K. Zalewski, PL |